PMC:7352545 / 3180-3329 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"69","span":{"begin":51,"end":59},"obj":"Species"},{"id":"70","span":{"begin":111,"end":121},"obj":"Species"},{"id":"97","span":{"begin":42,"end":50},"obj":"Disease"}],"attributes":[{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"Tax:9606"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"Tax:2697049"},{"id":"A97","pred":"tao:has_database_id","subj":"97","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"oV-2 preventive and therapeutic drugs for infected patients. In this review, the structure and sialobiology of SARS-CoV-2 are discussed in order to e"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T14","span":{"begin":111,"end":119},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"oV-2 preventive and therapeutic drugs for infected patients. In this review, the structure and sialobiology of SARS-CoV-2 are discussed in order to e"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T114","span":{"begin":32,"end":37},"obj":"Chemical"}],"attributes":[{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"oV-2 preventive and therapeutic drugs for infected patients. In this review, the structure and sialobiology of SARS-CoV-2 are discussed in order to e"}